News

Coronavirus

Reuters | Equities.com |

(Reuters) - A person’s blood type and other genetic factors may be linked with severity of coronavirus infection, according to European researchers looking for further clues about why COVID-19 hits some so much harder than others.The findings, published in The New England Journal of Medicine on Wednesday, suggest people with type A blood have a higher risk of being infected with the coronavirus and developing worse symptoms.At the peak of the epidemic in Europe, researchers analyzed the genes ...


Reuters | Equities.com |

NEW YORK (Reuters) - New York City will begin phase two of reopening on Monday, Mayor Bill de Blasio said on Thursday, citing continued improvements in coronavirus data. Offices, in-store retail, outdoor dining, hair salons and barbershops are among the businesses allowed to reopen their doors during phase two. “We’ve seen consistent progress and it is time to say to everyone get ready for phase two,” de Blasio told a daily news conference. De Blasio signed an executive order on Thursda...


Reuters | Equities.com |

BEIJING (Reuters) - China has found the trading sections for meat and seafood in Beijing’s wholesale food market to be severely contaminated with the new coronavirus and suspects the area’s low temperature and high humidity may have been contributing factors, officials said on Thursday. Their preliminary report comes as the country’s capital tackles a resurgence of COVID-19 cases over the past week linked to the massive Xinfadi food center, which houses warehouses and trading halls in an ...


MedCram | Equities.com |

Here's the latest update from Roger Seheult, MD, co-founder and instructor at MedCram. Dr. Seheult is an Associate Clinical Professor at the University of California, Riverside School of Medicine and an Assistant Clinical Professor at the School of Medicine and Allied Health at Loma Linda University. Dr. Seheult is certified in Internal Medicine, Pulmonary Diseases, Critical Care Medicine and Sleep Medicine through the American Board of Internal Medicine. In addition to being a preceptor f...


AP News | Equities.com |

BEIJING (AP) — China raised its emergency warning to its second-highest level and canceled more than 60% of the flights to Beijing on Wednesday amid a new coronavirus outbreak in the capital. It was a sharp pullback for the nation that declared victory over COVID-19 in March and a message to the rest of the world about how tenacious the virus really is. New infections spiked in India, Iran and U.S. states including Florida, Texas and Arizona as authorities struggled to balance restarting economic activity without accelerating the pandemic.


AP News | Equities.com |

FORT LAUDERDALE, Fla. — Florida’s confirmed coronavirus cases has risen sharply again and set a daily record weeks after the state began restarting its economy. The state Department of Health reported 2,783 new confirmed cases on Tuesday, breaking the record of 2,581 new cases set on Friday. The numbers on both days are almost double the previous high of 1,601 set in mid-May. The state also reported 55 more virus-related deaths for a total of 2,993. Gov. Ron DeSantis last week said the up...


Reuters | Equities.com |

(Reuters) - When the U.S. government announced a multibillion-dollar bailout of struggling small businesses amid the coronavirus pandemic, one of the top U.S. law firms sensed an opportunity. Leaders of the high-profile firm founded by David Boies circulated an email asking shareholder partners to authorize the firm to seek up to $20 million in forgivable government loans, two sources familiar with the matter told Reuters. Boies Schiller Flexner, where partners commonly earn s...


Reuters | Equities.com |

LONDON (Reuters) - Dexamethasone, a cheap and widely used steroid, has become the first drug shown to be able to save lives among COVID-19 patients in what scientists hailed as a “major breakthrough.” Results of trials announced on Tuesday showed dexamethasone, which is used to reduce inflammation in other diseases, reduced death rates by around a third among the most severely ill COVID-19 patients admitted to hospital. The results suggest the drug shoul...


MedCram | Equities.com |

Here's the latest update from Roger Seheult, MD, co-founder and instructor at MedCram. Dr. Seheult is an Associate Clinical Professor at the University of California, Riverside School of Medicine and an Assistant Clinical Professor at the School of Medicine and Allied Health at Loma Linda University. Dr. Seheult is certified in Internal Medicine, Pulmonary Diseases, Critical Care Medicine and Sleep Medicine through the American Board of Internal Medicine. In addition to being a pre...


Reuters | Equities.com |

(Reuters) - The U.S. Food and Drug Administration on Monday revoked the emergency use authorization for malaria drug hydroxychloroquine as a treatment for COVID-19, the use of which has been championed by U.S. President Donald Trump. The FDA said based on new evidence, it was no longer reasonable to believe that oral formulations of hydroxychloroquine and the related drug chloroquine may be effective in treating the respiratory illness caused by the novel coronavirus. The move comes after several studies of the drug suggested it was not effective, including a widely anticipated trial earlier this month showed it failed to prevent infection in people who have been exposed to the virus.